AVH News: AVITA Medical Submits FDA PMA Supplement to Further Expand Indication to Soft Tissue Repair - 13th Dec 2022, 1:15am

annb0t

Top 20
AVITA Medical

VALENCIA, Calif., and MELBOURNE, Australia, Dec. 12, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced today the submission of a Premarket Approval (PMA) supplement application to the U.S. Food and Drug Administration (FDA) for the company’s RECELL® System. The supplement, if approved,...

>>> Read more: AVITA Medical Submits FDA PMA Supplement to Further Expand Indication to Soft Tissue Repair
 
Top Bottom